Skip to content
Channels - Human Cases of Highly Pathogenic Avian Influenza A(H5N1) - California, September-December 2024 :: FRELIP Discovery
-
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure - San Francisco, California, December 2024-January 2025
-
Avian Influenza A(H5) Subtype in Wastewater - Oregon, September 15, 2021-July 11, 2024
-
Notes from the Field: Seroprevalence of Highly Pathogenic Avian Influenza A(H5) Virus Infections Among Bovine Veterinary Practitioners - United States, September 2024
-
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection of Indoor Domestic Cats Within Dairy Industry Worker Households - Michigan, May 2024
-
Zika Virus Outbreak - Bangladesh, September-December 2024
-
Highly Pathogenic Avian Influenza A(H5N1) Virus RNA in Bovine Semen, California, USA, 2024
-
Notes from the Field: Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater - Five European Countries, September-December 2024
-
Concurrent Norovirus Outbreaks Associated with Consumption of Oysters Harvested in Mexico - California, December 2023-January 2024
-
Human Rabies Deaths - Minnesota and California, 2024
-
CHARACTERIZATION AND COMPARATIVE SUSCEPTIBILITY OF HIGHLY PATHOGENIC AVIAN INFLUENZA H5N1 VIRUS INFECTIONS IN CHICKENS AND DUCKS
-
Outbreak of Salmonella Typhimurium Infections Linked to Commercially Distributed Raw Milk - California and Four Other States, September 2023-March 2024
-
Replication Efficiency of Contemporary Highly Pathogenic Avian Influenza A(H5N1) Virus Isolates in Human Nasal Epithelium Model
-
Influenza-Associated Pediatric Deaths - United States, 2024-25 Influenza Season
-
Influenza-Associated Hospitalizations During a High Severity Season - Influenza Hospitalization Surveillance Network, United States, 2024-25 Influenza Season
-
Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026
-
Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025
-
Introduction and inter-species transmission dynamics of high pathogenicity avian influenza H5N1 viruses in Japan 2021–25
-
Pediatric Influenza-Associated Encephalopathy and Acute Necrotizing Encephalopathy - United States, 2024-25 Influenza Season
-
Effectiveness of 2024-2025 COVID-19 Vaccines in Children in the United States - VISION, August 29, 2024-September 2, 2025
-
Notes from the Field: Outbreak of Escherichia coli O157:H7 Infections Linked to Organic Walnuts - Washington and California, 2024
-
Reports of Encephalopathy Among Children with Influenza-Associated Mortality - United States, 2010-11 Through 2024-25 Influenza Seasons
-
Influenza Vaccination Coverage Among Nursing Home Residents and Health Care Personnel - United States, 2024-25 Influenza Season
-
Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - California, October 2025-January 2026
-
Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025